
Mityzop-S 1g Injection
Marketer
Asiatic Pharmaceuticals
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Mityzop-S 1g Injection
Combiflox-1g Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial growth and propagation. Administration must be solely under a physician's direction; strict adherence to the prescribed schedule is crucial, completing the entire course even with symptom improvement. Premature cessation can compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek immediate help for allergic reactions (skin rashes, itching, edema, respiratory distress). Prior to use, inform your doctor of all medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are vital for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment efficacy.
Uses of Mityzop-S 1g Injection
Managing bacterial infections
Major Benefits of Mityzop-S 1g Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mityzop-S 1g Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Mityzop-S 1g Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mityzop-S 1g Injection works:
Mityzop-S 1g Injection unites Cefoperazone, a bacterial cell wall synthesis inhibitor antibiotic, with Sulbactam, a beta-lactamase inhibitor. This synergistic combination combats bacterial infection by disrupting bacterial integrity and overcoming resistance mechanisms, thereby improving Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingesting alcohol during treatment with Mityzop-S 1g Injection can lead to adverse effects including facial redness, tachycardia, nausea, dehydration, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable formulation of Mityzop-S (1g) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation Mityzop-S (1g) is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no identified risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Mityzop-S 1g Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mityzop-S 1g Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mityzop-S 1g Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mityzop-S 1g Injection :
Omitting a scheduled dose of Mityzop-S 1g Injection necessitates contacting your physician.
Facts to Know About Mityzop-S 1g Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Agents against infection |
